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Abstract
Cross-talk between NK cells and dendritic cells (DCs) is critical for the potent therapeutic
response to dsRNA, but the receptors involved remained controversial. We show in this paper that
two dsRNAs, polyadenylic-polyuridylic acid and polyinosinic-polycytidylic acid [poly(I:C)],
similarly engaged human TLR3, whereas only poly(I:C) triggered human RIG-I and MDA5. Both
dsRNA enhanced NK cell activation within PBMCs but only poly(I:C) induced IFN-γ. Although
myeloid DCs (mDCs) were required for NK cell activation, induction of cytolytic potential and
IFN-γ production did not require contact with mDCs but was dependent on type I IFN and IL-12,
respectively. Poly(I:C) but not polyadenylic-polyuridylic acid synergized with mDC-derived
IL-12 for IFN-γ production by acting directly on NK cells. Finally, the requirement of both TLR3
and Rig-like receptor (RLR) on mDCs and RLRs but not TLR3 on NK cells for IFN-γ production
was demonstrated using TLR3- and Cardif-deficient mice and human RIG-I–specific activator.
Thus, we report the requirement of cotriggering TLR3 and RLR on mDCs and RLRs on NK cells
for a pathogen product to induce potent innate cell activation.
Natural killer cells are potent cytotoxic cells capable of killing infected or tumor cells (1)
and are also able of producing proinflammatory cytokines including IFN-γ and TNF. These
cytokines are crucial in the enhancement of the innate resistance by activating macrophages
and neutrophils but also regulate the adaptive immune response (2).
Although NK cells can directly sense infections and cellular transformation, in part by
recognizing stress-associated surface markers, many studies have outlined the importance of
accessory cells (ACs) in modulating their function (3). Activated NK cells induce dendritic
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cell (DC) maturation (4, 5) through both TNF/IFN-γ secretion and cell–cell contact
involving NKp30 (5–7). In turn, cytokine production by activated DCs enhances NK cell
IFN-γ production, proliferation, and cytotoxic potential (4, 5, 8–10). IL-12 is essential for
IFN-γ production by innate lymphocytes (11) and the enhancement of antitumor and
antiviral activity in vivo (12). This DC/NK cross-talk has been reported to be critical in Th1
and CTL responses (13–15).
DCs sense viral infection through motifs that are conserved between large classes of
pathogens and bind to germline-encoded receptors (16). Among these receptors, the TLR3
(17) and more recently the cytosolic helicase MDA5 (18, 19) have been described to sense
synthetic dsRNA or viral infection, leading to strong type I IFN production and contributing
to inflammatory cytokine production (20). Furthermore, a mouse vaccination study showed
that the production of type I IFN by DCs upon engagement of MDA5 and TLR3 by
polyinosinic-polycytidylic acid [poly(I:C)] was required for Th1 driving CD4+ T cell
immunity (21), illustrating the therapeutic potential of poly(I:C) in vaccination relative to
other TLR agonists.
The role of ACs in dsRNA-mediated NK cells activation remains unclear. Both ACs-
dependent (5, 22, 23) and -independent activation (24–27) of NK cells have been reported.
The aim of the current study was to decipher the involvement of ACs in dsRNA-mediated
NK cells response and to characterize the dsRNA receptors on DC and NK involved in this
response. We used three synthetic ligands: poly (I:C) dsRNA that triggers both TLR3 and
Rig-like receptor (RLR) pathways, polyadenylic-polyuridylic acid [poly(A:U)] dsRNA that
displays specificity for TLR3, and 5′-triphosphate ssRNA (3pRNA) that engages only the
RIG-I helicase. We demonstrated that mDCs are required for NK cells activation in response
to dsRNA. Most importantly, the specificity of the three ligands and the use of TLR3−/− and
Cardif−/− mice allowed us to demonstrate that the full activation of NK cells and especially
the production of IFN-γ, in response to dsRNA required the triggering of both TLR3 and
RLR on myeloid DCs (mDCs) and RLRs on NK cells. Our study deciphers the mechanisms
of dsRNA-induced NK cell physiological response and supports the novel concept that a
single pathogen product can lead to potent innate cell activation, because it engages different
classes of receptors expressed by different cell types.
Materials and Methods
Reagents
dsRNA or recombinant cytokines were used at indicated concentrations: 1300 kDa poly(I:C)
(InvivoGen, San Diego, CA), standardized high molecular mass poly(A:U) (Innate-Pharma,
Marseille, France), IFN-β (PBL Biomedical Laboratories, Piscataway, NJ), IFN-α2b
(IntronA; Schering-Plough, Kenilworth, NJ), IL-12, or IL-15 (R&D Systems, Minneapolis,
MN). 3pRNA was synthesized and purified with the MEGAscript and MEGAclear kits,
respectively (Ambion, Austin, TX). The following neutralizing mAbs were used: 20 μg/ml
mouse anti-human IFN-αβR2 (PBL Biomedical Laboratories) or 10 μg/ml mouse anti-
human IL-12p70 (clone 20C2) and mouse anti-human IL-15 (R&D Systems). Twenty
micrograms per mililiter mouse IgG was used as control (R&D Systems). All these mAbs
were previously validated using the corresponding recombinant cytokine on relevant NK
activation parameters (data not shown).
Cell purification
From human blood of healthy donors—NK cells were selected by depletion using the
NK cells isolation kit, whereas mDCs and monocytes were positively selected with,
respectively, anti-BDCA1 plus -BDCA3 and -CD14 microbeads (Miltenyi Biotec, Auburn,
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CA). Purities of NK cells, monocytes, and mDCs were 98.5 ± 0.8, 99.1 ± 0.2, and 94.2 ±
2.6%, respectively. In some experiments, whole PBMCs or depleted in monocytes, mDCs,
or plasmacytoid DCs (pDCs) with, respectively, anti-CD14, -BDCA1 plus -BDCA3, and -
BDCA4 microbeads (Miltenyi Biotec) were treated with dsRNA.
For real-time PCR, NK cells and mDCs were stained with anti-CD56PE plus -CD3FITC (for
NK) or anti-CD3, -CD14, -CD56, and CD35FITC (lineage) plus -CD4PECy5.5 plus
CD11cAPC mAbs (BD Biosciences, San Jose, CA) (for mDCs) and sorted with a
FACSVantage cell sorter (BD Biosciences) by gating on CD56+CD3− (NK cells) or
lineage-CD4+ CD11c+ (mDCs) cells. Final purity of NK cells and mDCs were 99.5 ± 0.3
and 98.7 ± 0.5%.
From spleen of C57BL/6 mice—Spleens from wild-type, TLR3−/− (17), Cardif−/−, (28),
and C57BL/6 mice were dilacerated and B, T, and erythroid cells depleted with anti-CD19, -
CD3 -Ter119 (BD Biosciences), and sheep anti-rat Ig Dynabeads (Dynal, Oslo, Norway).
DX5+ NK cells and CD11c+ DCs were then positively selected with anti-DX5 and anti-
CD11c microbeads, respectively (Miltenyi Biotec). Purities of NK cells and DCs were 87.8
± 2.4 and 86.4 ±6.1%, respectively.
dsRNA-activated DC supernatant generation
MACS-sorted mDCs or in vitro-generated monocyte-derived DCs (MdDCs) were incubated
with 30 μg/ml poly(I:C) or poly(A:U) for 24 h (continuous treatment) or pulsed for 4 h,
washed three times in PBS, and incubated for 20 supplementary h (pulse treatment).
Supernatants (SNs) were harvested, filtered through a 0.22-μm membrane, and used to
stimulate purified NK cells diluted as indicated, alone or in combination with 30 μg/ml
poly(I:C) or poly(A:U).
Cell activation follow-up
CD107-based degranulation assay—Twenty-hour–activated effectors (PBMCs, NK
cells alone, or with mDCs) were seeded in 96-well plates with HCC1806 breast cancer target
cell line (American Type Culture Collection, Manassas, VA) at an E:T ratio of 10:1 for
PBMCs and 1:1 for NK cells. Anti–CD107aPE-Cy5 mAb (1/20) and monensin (1/1500)
(BD Biosciences) were added. After 4 h at 37°C, cells were stained with anti-CD56PE and -
CD3FITC and analyzed by flow cytometry. Percentage of CD107a-expressing cells among
CD56+CD3− NK cells was determined.
Cytokine quantification—SNs of 20-h–activated human PBMCs, mDCs, or NK cells ±
mDC cultures were collected and production of IFN-γ, IL-12p40, IL-12p70, IL-15 (BD
Biosciences), and IFN-β (BioSource International, Camarillo, CA) was determined by
ELISA. Mouse IFN-γ (BD Biosciences) was also quantified by ELISA in SNs of 20-h–
activated mouse NK cells ± conventional DC (cDC) cultures.
In some experiments, IFN-γ was quantified by cytometry-based intracellular staining. A
total of 2 × 106 PBMCs were activated or not with poly(I:C) for 2 h before addition of
brefeldin A (BD Biosciences) for the last 6 h of culture. Cells were then stained with anti-
CD56PE, -CD3PE-Cy5.5, -CD4PE-Cy7 (BD Biosciences), and -Vγ9FITC (Innate Pharma)
mAbs. Cells were then fixed and permeabilized using Cytofix-Cytoperm kit, stained with
anti–IFN-γ APC mAb (BD Biosciences), and analyzed by flow cytometry. Cells were gated
on the IFN-γ–positive cells, and the percentage of γδ T cells, NK cells, NKT-activated T
cells, and CD4+ and CD8+ T cells was determined.
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Stable expression in HEK293T
HEK293T cell line (American Type Culture Collection) was transfected using FuGene 6
(Roche, Basel, Switzerland) with 5 μg pISRE-TA-luciferase plasmid (BD Clontech, Palo
Alto, CA) and 500 ng of the pTK-Hyg plasmid (Invitrogen, Carlsbad, CA) containing
hygromycin resistance gene. After an overnight incubation, transfected cells were selected
with 150 μg/ml hygromycin B (Invitrogen), cloned by limiting dilution. and analyzed for
luciferase activity in response to IFN-α2b. A responding clone was transfected as described
above with 2 μg pUNO-hTLR3, pUNO-hMDA5, and pUNO-hRIG-I plasmids (InvivoGen)
containing blasticydin resistance gene. Transfected cells were selected with 10 μg/ml
blasticydin (Invitrogen), cloned, and analyzed for specific gene expression by real-time
PCR.
Luciferase assay
A total of 4 × 104 TLR3-, RIG-I–, and MDA5-expressing cells or control cells were seeded
into 96-well plates (MicroClear-96; Greiner Bio One, Courtaboeuf, France) and incubated
for 20 h at 37°C. Cells were then activated for 6 h at 37°C with poly(I:C), poly(A:U),
3pRNA, or IFN-α2b (100 UI/ml). Luciferase activity was measured on a TopCount NXT
apparatus (Packard Instrument, Meriden, CT) after addition of the Steady-Glo reporter assay
reagent (Promega, Madison, WI). Results were expressed as a ratio between stimulated and
nonstimulated cells. In some experiments, results were normalized to the IFN-α2b response
to compare ligands efficacy.
Biacore assay
Biacore T100 apparatus (Biacore Life Sciences, GE Healthcare, Fairfield, CT) was used for
these experiments. Recombinant human TLR3 (rhTLR3; R&D Systems) was immobilized
onto the dextran layer of a Biacore CM5 Series S sensor chip by injecting rhTLR3 (10 μg/
ml) until reaching the desired immobilization level (~3000 RU). A total of 10 μg/ml
poly(A:U) or poly(I:C) were injected onto rhTLR3 surface at a flow rate of 10 μl/min.
Injection was performed for 120 s, followed by a dissociation period of 180 s. Sensorgam
curves were analyzed using BiaEvaluation software version 4.1.
Real-time PCR
Total mRNA was extracted from cells of interest and cDNA was synthesized using RNeasy
Plus and QuantiTect RT Kits, respectively (Qiagen, Valencia, CA). GAPDH was used as a
housekeeping gene. PCRs were performed with the QuantiTect SYBR Green PCR kit
(Qiagen), primers, and 20 ng cDNA on a MX3000P thermocycler (Stratagene, La Jolla,
CA). GAPDH, RIG-I, and MDA5 primers were purchased from Qiagen. TLR3 primer
sequences were as follows: 5′-TGGTTGGGCCACCTAGAAGTA-3′ (forward) and 5′-
TCTCCATTCCTGGCCTGTG-3′ (reverse). Cycling conditions were as follows: 1 cycle of
10 min at 95°C; 40 cycles of 30 s at 95°C, 1 min at 60°C and 30 s at 72°C; and 1 cycle of 1
min at 95°C, 30 s at 55°C, and 30 s at 95°C. Because of using primer pairs that amplified
two or more exons from a unique gene, genomic contamination was excluded by melting
curve analysis. Gene expression was calculated as the ratio between gene of interest and
GAPDH using the MxPRO QPCR software (Stratagene).
Statistical analysis
Statistical analyses were performed using GraphPad Prism version 5.1 software. Student t
test (two-tailed) was used in the study.
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Results
Both poly(I:C) and poly(A:U) signal via TLR3 but only poly(I:C) triggers RIG-I or MDA5
To determine the ability of dsRNA to trigger type I IFN production through TLR3 and RLR,
HEK293T cells stably expressing the pISRE-TA-luciferase plasmid were transfected with
plasmids encoding human TLR3, RIG-I, or MDA5. The transfected or control cell lines
were stimulated for 6 h with different doses of poly(I:C) and poly(A:U) dsRNA or with 100
UI/ml IFN-α2b as internal calibrator and luciferase activity were measured. The activity of
dsRNA was normalized to the response to IFN-α2b. Both dsRNAs triggered TLR3 with the
same efficiency, but a specific response in RIG-I– and MDA5-transfected cells was
observed only with poly(I:C) (Fig. 1A). A high concentration (100 μg/ml) of poly(A:U)
only induced a weak response in RIG-I– and MDA5-expressing cell lines comparable to that
also detected on cells expressing ISRE-TA-luciferase, only suggesting activation of
endogenous TLR3 that appeared to be expressed at low levels in 293T cell line, as detected
by real-time PCR (Supplemental Fig. 1).
We then tested both dsRNA on an rhTLR3-coated sensor chip analyzed using a Biacore
T100 apparatus. Poly(A:U) and poly(I:C) displayed an identical avidity for binding to TLR3
as indicated by the association/dissociation curves of the dsRNA (Fig. 1B), confirming that
poly(A:U) and poly(I:C) triggered TLR3 with the same efficiency.
Altogether, these results demonstrate that poly(A:U) and poly(I:C) signal via TLR3 with the
same efficiency, but only poly(I:C) triggers the RLR pathway via RIG-I and/or MDA5.
Within PBMCs, poly(I:C) and poly(A:U) lead to different qualitative NK cell activation
Human PBMCs were cultured with either dsRNA. After 20 h, IFN-γ was quantified in the
SN, and following an additional 4-h coculture with HCC1806 breast cancer target cells,
degranulating CD56+ CD3− NK cells were identified by the expression of CD107. The two
dsRNAs enhanced NK cell degranulation with the same efficiency (Fig. 2A, left panel), but
poly(I:C) was much more efficient than poly(A:U) (p < 0.0001 between 1 and 100 μg/ml
dsRNA) to induce IFN-γ production (Fig. 2A, right panel). As detected by intracellular
staining, NK cells represented the majority of IFN-γ–producing cells in poly(I:C)-activated
PBMCs with a minor participation of CD8+, CD3+CD56+, and γδ T cells (Fig. 2B).
This differential activity of dsRNA suggests that the induction of degranulation is mainly
dependent on the TLR3 pathway activation shared by poly(I:C) and poly(A:U), whereas
optimal IFN-γ induction required additional signaling through the RLR engaged by
poly(I:C) exclusively.
mDCs are required for NK cell activation in response to dsRNA
To analyze the requirement of ACs in the human NK cell response to dsRNA, PBMCs were
immunomagnetically depleted of various cell populations before culture with poly(I:C) or
poly(A:U), and CD107 expression and IFN-γ production were analyzed. Depletion of
mDCs (BDCA1+3) before activation with either dsRNA dramatically decreased the
cytolytic activity and completely abrogated the production of IFN-γ (Fig. 3A), whereas
depletion of monocytes (CD14) and pDCs (BDCA4) had no effect. To further confirm the
role of mDCs in dsRNA-mediated activation of NK cells, both cell types were purified by
immunomagnetic sorting and activated either separately or in coculture. Using purified NK
cells, the two dsRNA did not induce IFN-γ production or CD107 (Fig. 3B); however, in the
presence of mDCs, both dsRNA similarly enhanced the cytotoxic activity of purified NK
cells, whereas poly(I: C) was much more efficient than poly(A:U) in triggering IFN-γ
production.
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To link these biological activities with the receptor selectivity of poly(I:C) and poly(A:U),
we then determined the levels of dsRNA receptor expression by real-time PCR on
nonactivated cell populations. The three studied mRNAs were detected on MdDCs and
mDCs but, except RIG-I, were much less expressed in NK cells (Fig. 3C).
These observations demonstrated that dsRNA-mediated activation of NK cells required the
participation of mDCs that were likely activated by poly(I:C) and poly(A:U) through
engagement of TLR3. However, the higher activity of poly(I:C) than poly(A:U) for IFN-γ
induction suggested the contribution of another dsRNA receptor (likely an RLR) on mDCs
and/or NK cells.
IL-12 and IFN-β produced by dsRNA-activated mDCs contribute to activate NK cells
We next addressed whether soluble mediators produced by human dsRNA-activated mDCs
were involved in the NK cell response to dsRNA. dsRNA-activated mDC SNs generated by
treating cells for 20 h were used to stimulate purified NK cells. SNs of mDCs activated for
20 h with the same dose of either dsRNA were sufficient to activate NK cell cytolytic
activity (Fig. 4A), whereas SNs generated with poly(A:U) were much less efficient than
those generated with poly(I:C) to induce IFN-γ.
NK cells were treated with dsRNA-activated DC SNs with or without neutralizing Abs. The
blockade of type I IFNR significantly diminished NK cell degranulation [p = 0.048 for
poly(I:C) and p = 0.010 for poly(A:U)] but not the production of IFN-γ (Fig. 4B). IL-12
neutralization had no effect on the CD107 staining, whereas the production of IFN-γ was
completely abrogated [p = 0.0005 for poly(I:C) and p = 0.0009 for poly(A:U)]. No effect
was observed when IL-15 was blocked.
Poly(I:C) and poly(A:U) were equally effective in inducing type I IFNs production by
purified mDCs (Fig. 4C) or whole PBMCs (Fig. 4D), whereas poly(I:C) was a stronger
inducer of IL-12p70 than poly(A:U). Of note, when PBMCs were depleted of their mDC
fraction (BDCA1+3), IFN-β production was totally abrogated and dramatically decreased in
response to poly(A:U) and poly(I:C), respectively (Supplemental Fig. 2), suggesting that
mDCs were the main producers of type I IFN within PBMCs in response to dsRNA.
Finally, upon activation with IFN-β or poly(I:C), but not with poly(A:U), the levels of RIG-I
and MDA5 transcripts in highly purified FACS-sorted NK cells were increased 50- to 100-
fold, whereas the level of TLR3 transcripts remained very low (Fig. 4E). In addition, as
shown in Fig. 4F, poly(I:C) significantly increased the level of IFN-β mRNA in purified NK
cells as compared with medium (p = 0.022) or poly(A:U) (p = 0.021), indicating that the
regulation of an RLR was presumably dependent on type I IFN.
These observations demonstrated that soluble mediators produced by dsRNA-activated
mDCs participated in NK response to dsRNA and that type I IFN mainly contributed to the
enhancement of cytotoxic activity and IL-12 to IFN-γ production. Furthermore, poly(I: C)
and poly(A:U) engaged at least TLR3 on mDCs, leading to IFN-β secretion that upregulated
the expression of RLRs on NK cells.
Requirement of direct effect of poly(I:C) on NK for IFN-γ production
Because, in the experiments described above we could not rule out the presence of
remaining dsRNA within the mDC SNs, the contribution of mDC-produced soluble factors
was mimicked using rIL-12 and type I IFN to decipher a possible contribution of direct
activation of NK cells through one of the dsRNA receptor. We treated MACS-sorted NK
cells with a different doses of rIL-12 or IFN-β alone or in the presence of poly(I:C) or
poly(A:U). IFN-β alone triggered a strong cytolytic activity of NK cells but did not induce
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IFN-γ (Fig. 5A, upper panel). IL-12 alone was a weak NK cell activator in both readouts
(Fig. 5A, lower panel). However, poly(I:C) but not poly(A:U) synergized with IL-12 to
induce a strong activation of purified NK cells, suggesting that poly(I:C) directly engaged
NK cells for the production of IFN-γ and that NK cells do not express receptors for
poly(A:U) even after priming with IL-12 or IFN-β.
We next produced SNs from mDCs pulsed with dsRNA for 4 h, extensively washed and
cultured for an extra 20 h to avoid contaminating dsRNA in the SNs. Although SNs from
pulsed mDCs induced CD69 expression, they were unable to induce IFN-γ production
unlike SNs from mDCs continuously stimulated with dsRNA (Supplemental Fig. 3A).
We next performed experiments with MdDC SNs that displayed almost the same efficiency
than mDC SNs to activate NK cells (Supplemental Fig. 3B). Poly(I:C) synergized with
poly(I:C)-pulsed MdDC SNs to trigger the production of IFN-γ by MACS-sorted NK cells
(Fig. 5B), with an 18-fold increase compared with SN alone. Using poly(A:U) continuously
treated MdDC SNs, we observed a similar synergy with poly(I:C) for IFN-γ production by
NK cells. In contrast, the addition of poly(A:U) on NK cells did not synergize with any of
the pulsed DC SNs (Fig. 5B), in line with the absence of poly(A:U)-interacting receptors on
NK cells.
Collectively, our results suggest that dsRNA treatment of mDCs induced the production of
IL-12 that synergized with a TLR3-independent and probably RLR-dependent direct effect
of poly(I: C) on purified NK cells for IFN-γ production.
Synergy between TLR3 and RLR engagement on mDCs and RLRs on NK cells for IFN-γ
production
As in humans, poly(I:C) synergized with IL-12 to induce the production of IFN-γ by
purified mouse NK cells (Fig. 6A). With the aim of confirming that the direct effect of
poly(I:C) on NK cells was TLR3 independent, we performed experiments with mouse DX5+
NK cells and CD11c+ DCs purified from TLR3 or Cardif-deficient and -sufficient mice. The
synergy between poly(I:C) and IL-12 was observed with WT and TLR3−/− but not Cardif−/−
NK cells, demonstrating that the direct effect of poly(I:C) on NK cells was RLR dependent
but TLR3 independent. As a control, IL-2 used in combination with IL-12 showed that WT,
TLR3−/−, and Cardif−/− NK cells produced almost the same amount of IFN-γ (Fig. 6A). In
coculture experiment using purified NK cells from either WT, TLR3−/−, or Cardif−/− and
DCs from WT mouse spleen, IFN-γ production induced by poly(I:C) also required the RLR
but not the TLR3 pathway on NK cells (Fig. 6B). Finally, IFN-γ production was completely
abrogated and 70% reduced when WT NK cells were cocultured with DCs from TLR3−/−
and Cardif−/− mice, respectively (Fig. 6C). When activated with LPS (TLR4), DCs from
WT, TLR3−/−, or Cardif−/− mice induced IFN-γ production in NK cells. These observations
demonstrated the crucial requirement of both TLR3 and RLR on DCs but of only the RLR
on NK for production of IFN-γ in response to poly(I:C).
To further confirm that the triggering of the RLR pathway on human NK cells was involved
in the production of IFN-γ, we stimulated MACS-sorted NK cells with 3pRNA, a newly
described RIG-I–specific ligand (29, 30) (Supplemental Fig. 4). We then observed that
3pRNA synergized with IL-12 to enhance IFN-γ production by NK cells similarly to
poly(I:C) but unlike poly(A: U) (Fig. 6D). In addition, the combination of 3pRNA and
poly(A: U) induced IFN-γ production in NK-DC cocultures at levels comparable to those
induced by poly(I:C) (Fig. 6E). Altogether, these results demonstrate that TLR3 and RLR
engagement on DCs and RIG-I on NK are required for optimal IFN-γ production by NK.
The mechanisms deciphered along the study concluding that the optimal production of IFN-
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γ by NK cells required the concomitant engagement of TLR3 and RLRs on mDCs and
RLRs on NK cells by dsRNA are depicted in Fig. 7.
Discussion
In the current study, we report the first evidence that optimal NK cell response to synthetic
dsRNA requires the triggering of both TLR3 and RLR on mDCs and RIG-I on NK cells
(Fig. 7). In particular, we show that 1) NK cell activation in response to dsRNA required the
presence of mDCs; 2) poly(I:C) dsRNA (an agonist for both TLR3 and RLR) and 3pRNA
(an agonist for RIG-I) but not poly(A:U) dsRNA (an agonist for TLR3 only) directly
activated NK cells leading to high IFN-γ production in synergy with mDC-released soluble
mediators induced by either dsRNA; and 3) TLR3 and RLR expression were required on
mDCs, whereas RLR was needed on NK cells for IFN-γ production in response to dsRNA.
In Biacore experiments and in the luciferase assay with TLR3-transfected cell line (Fig. 1A,
1B), poly(A:U) and poly(I:C) showed similar efficiency (identical avidity and potency) to
bind to and trigger TLR3. In contrast, using RLR-overexpressing cell lines, only poly(I:C)
activated the two RLRs, RIG-I and MDA5. Our results are in agreement with the study of
Kato et al. (31), showing that dsRNA is recognized by either RIG-I or MDA5, although in a
length-dependent way.
DC depletion and NK-DC coculture experiments established that mDCs were critical for
dsRNA-mediated NK cell activation. These observations are in agreement with several
studies both in humans (5) and in mouse models (22) showing the mandatory role of mDCs
or conventional CD11c+ DCs, respectively, for NK cells activation upon treatment with
synthetic poly(I:C). Numerous reports deciphered the interplay between NK cells and DCs
leading to the complete activation of both cell types (4, 6, 9, 10, 32) and to the establishment
of the innate and adaptive immune responses involved in the control of viral infection (33,
34) or tumor growth (8). In particular, using an inducible and selective ablation system of
CD11c+ DCs, Lucas et al. (35) have shown that naive NK cells do not acquire effector
functions without prior priming by contact with cDCs in draining lymph nodes.
We show in our experimental model, that for DC/NK cooperation, cell-to-cell contact was
not required. Type I IFN and IL-12 produced by either poly(I:C)- or poly(A:U)-activated
mDCs were sufficient to enhance the cytolytic potential and IFN-γ production by NK cells,
respectively. This is in agreement with previous reports that highlighted the respective role
for IL-12 and type I IFN in the production of IFN-γ and the cytolytic potential of NK cells
(5, 12, 36). In several other experimental settings, a direct contact between NK cells and
DCs (membrane IL-15 and NKp30) was shown to participate in efficient NK cells triggering
(8, 32). To examine the role of dsRNA receptors on NK, our study focused on soluble
mediators, but a role for membrane interaction between NK cells and DC was not excluded.
The fact that both poly(A:U) and poly(I:C) induced the secretion of soluble mediators from
mDCs leading to NK cell activation clearly suggested that the dsRNA activity on mDCs was
at least dependent on TLR3. This observation is in agreement with several studies
demonstrating the involvement of TLR3 on mDC response to poly(I:C) (4, 5, 22). However,
although both dsRNAs induce comparable levels of type I IFN, poly(I:C) induced
significantly higher levels of IL-12p70 suggesting the engagement of a receptor was distinct
from TLR3 for the optimal IL-12p70 production by mDCs. Experiments performed with
mouse CD11c+ DCs deficient for TLR3 or Cardif expression confirmed that TLR3 and also
RLRs on DCs were required for the dsRNA-mediated DC-dependent NK cell activation,
notably IFN-γ production. McCartney et al. (37) showed that production of IL-12p40 in
response to an in vivo injection of poly(I:C) was totally abrogated in TLR3−/− mice but not
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in MDA−/− mice. This observation might appear in contradiction with our results showing
an abrogation or a dramatic diminution of IFN-γ production by NK cells when cocultured
with DC from TLR3−/− or Cardif−/− mice, respectively. However, the involvement of RIG-I
was not explored in the study of McCartney et al. (37).
The synergistic activity between DC-derived soluble mediators and poly(I:C) acting on
purified NK cells demonstrated a direct effect of dsRNA on NK cells. Furthermore, the
biological responses observed with purified human NK cells and mouse TLR3- or Cardif-
deficient NK cells unambiguously demonstrated that the direct effect of poly(I:C) on NK
cells is RLR dependent and TLR3 independent. The fact that the RIG-I agonist 3pRNA
mimicked the ability of poly(I:C) to activate NK cells further confirm the role of RLRs on
human NK cells for induction of IFN-γ in synergy with IL-12. In addition, upon treatment
of NK with type I IFN or poly(I:C), the expression of both RIG-I and MDA5 was
significantly enhanced, whereas TLR3 was still only marginally expressed (Figs. 3C, 4E).
Similarly to our results, Tu et al. (23) showed that poly(I:C)-treated Kupffer cells allowed
NK cells to produce IFN-γ after a direct sensing of poly(I:C), but these authors did not
identify the dsRNA receptor involved on NK cells.
Our present conclusion that in NK cells poly(I:C)-mediated activation of RLRs and in
particular RIG-I but not TLR3 play an important role in enhancing the production of IFN-γ
in response to DC-produced cytokines such as IL-12 is based on several lines of evidence
both in human and mouse cells. However, this conclusion may appear in contradiction with
previous studies suggesting that NK cells directly respond to dsRNA in a TLR3-dependent
manner (25, 26, 38, 39). Sivori et al. (26), in particular, demonstrated a convincing
correlation between poly(I:C)-mediated activation and TLR3 mRNA expression in in vitro-
expanded clones of IL-2–activated NK cells. However, these results were obtained using in
vitro-expanded NK cell clones that may have upregulated TLR3 upon activation and, thus,
do not contradict our own results that have been obtained with freshly purified resting NK
cells and that may more closely reproduce the physiological NK response to infection in
naive organisms. Most other studies did not exclude the contribution of other dsRNA
receptors expressed by NK cells. The discovery that viral dsRNA and poly(I:C) are capable
of triggering receptors other than TLR3 and in particular the RLRs family is recent (18, 31,
40, 41), and most other studies on NK cells have not directly tested the contribution of
RLRs. However, our results demonstrating a critical role for RLRs on NK cells are in
contradiction with Miyake et al. (42) and McCartney et al. (37) recent reports that failed to
identify a role of either RLR or MDA5 on NK cells for IFN-γ production in DC-NK
cultures in response to poly(I:C). The reason for this discrepancy is unclear but might be due
to different experimental conditions that may mask the requirement for RLRs on NK cells.
Taken together with the recent work of Lucas et al. (35), our observations would suggest
that in vivo mDCs activated through TLR3 migrate into the draining lymph node and
produce cytokines, leading to NK cell priming. Then, upon recirculation and access to the
inflamed tissues, primed NK cells would directly respond to viral invasion through lytic
synapse and pathogens components transfer and sensing through cytosolic helicases. This
secondary activation of the primed NK cells would further enhance their ability to kill
infected or transformed cells and would induce the production of inflammatory cytokines
contributing to the shaping of the adaptive immune response (39). These observations are
consistent with the concept that, to trigger a productive innate immune response, viruses
need to engage different classes of receptors either constitutively expressed or induced on
different cell types. Other known examples that support this concept include
imidazoquinolines (43) compounds that mimic microbial components by triggering TLR7/8
and cryopyrin/NALP3 (44) as well as peptidoglycan, which triggers several receptors
including TLR2 (40) and NOD1 (41, 42). Thus, suggesting that this concept may also apply
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to some bacteria; however, in our experimental conditions, we could not detect such
cooperation for LPS-induced IFN-γ by NK cells. A similar scenario involving synergy
between different TLRs expressed within different cellular compartments on a unique DC
type (45) or cooperation between different DC types (39) have been suggested as a
requirement to mount an appropriate immune response against a single pathogen. Our model
strengthens the notion that powerful but also potentially harmful immune effector
mechanisms are elicited only in response to those invading pathogens that the immune
system senses cooperatively through multiple cells, compartments, and receptors.
Furthermore, Longhi et al. (21) showed that the production of type I IFN by DCs in response
to poly(I:C) as adjuvant that triggered both TLR3 and RLR pathways leads to a strong
adaptive immunity. This study clearly highlighted the clinical potential of a drug with
specificity for TLR3 and RIG-I/MDA5 or of two drugs specific for each pathway. The
combination of different products that act individually on each receptor will allow to tune
very finely the immune response and to ensure the safety of the treatment.
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AC accessory cell
cDC conventional dendritic cell
DC dendritic cell
mDC myeloid dendritic cell
MdDC monocyte-derived dendritic cell
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pDC plasmacytoid dendritic cell
p(IC), poly(I:C); poly(I:C) polyinosinic-polycytidylic acid
3pRNA 5′-triphosphate ssRNA
rhTLR3 recombinant human TLR3
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FIGURE 1.
P(AU) and p(IC) show an identical potency for TLR3 engagement whereas only p(IC)
triggers RLRs. A, A total of 4 × 105/ml human HEK293T cells stably expressing the pISRE-
TA-luciferase plasmid were transfected with plasmids encoding human TLR3, RIG-I, or
MDA5. Transfected or control HEK293T were stimulated with p(IC), p(AU), or with IFN-α
(100 IU/ml), and luciferase activity was determined. Results were expressed as a ratio
between stimulated and nonstimulated cells and normalized to IFN-α response. Data
represent mean + SD of five independent experiments. B, p(AU) or p(IC) and control
ssRNA poly(A), poly(U), poly(I), and poly(C) were injected onto rhTLR3-coated chip and
analyzed on a Biacore T100 apparatus. Injection (open arrowhead) was performed for 120 s,
followed by a dissociation period (filled arrowhead) of 180 s. Data are presented as one of
three representative experiment. p(AU), poly(A:U); p(IC), poly(I:C).
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FIGURE 2.
Both poly(I:C) and poly(A:U) trigger NK cell activation within PBMCs, but only poly(I:C)
induces high IFN-γ production by NK cells. A, A total of 2 × 106/ml human PBMCs were
stimulated for 20 h with poly(I:C) and poly(A:U). Culture SNs were collected to determine
the production of IFN-γ by ELISA (right panel). Cells were additionally incubated for 4 h
with the HCC1806 target cell line to quantify the degranulating NK cells (CD56+CD3−) in a
CD107 flow cytometry-based assay (left panel). Data are from one representative
experiment (with SD on culture triplicates) of five performed with five different donors. B,
A total of 2 × 106/ml human PBMCs were stimulated for 2 h with 30 μg/ml poly(I:C) before
addition of brefeldin A for the last 6 h of culture. Cells were stained as described in
Materials and Methods analyzed by flow cytometry by gating on the IFN-γ–positive
fraction. Data are expressed as the percentage of different cell subsets within IFN-γ–
producing cells. Data represent independent values of seven different donors, and horizontal
bars represent the median.
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FIGURE 3.
mDCs are required for NK cells activation in response to dsRNA. NK cells activation was
evaluated by CD107a staining (upper panels) and the IFN-γ production (lower panels), as
described (Fig. 1). A, A total of 2 × 106/ml whole human PBMCs or depleted in myeloid
cells (CD33), monocytes (CD14), pDCs (BDCA4), or mDCs (both BDCA1 and BDCA3
subtypes) were activated with the indicated concentrations of p(IC) and p(AU). B, 1 × 106/
ml MACS-purified human NK cells were activated with the indicated concentrations of
p(IC) and p(AU) with or without 2 × 105/ml MACS-purified blood mDC (both BDCA1 and
BDCA3 subtypes). Data from A and B represent independent values of four and three
different donor, respectively. C, RIG-I, MDA5, and TLR3 mRNA levels were determined in
the three different cell types using real-time PCR. Results are expressed as arbitrary units
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normalized to value for the housekeeping gene GAPDH. Data represent independent values
of four to six different donors and horizontal bars the median. *p < 0.05; ***p < 0.001.
p(AU), poly(A:U); p(IC), poly(IC).
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FIGURE 4.
IL-12 and type I IFN secreted by dsRNA-activated mDCs mediate NK cells activation. A,
SNs from MACS-sorted mDCs (BDCA1 and BDCA3) activated with p(IC) (open
histograms) or p(AU) (filled histograms) were used in a dose range to activate 1 × 106/ml
MACS-purified human NK cells. Degranulation and IFN-γ production are evaluated as
described (Fig. 2). Data are from of one of three representative experiments (mean of
duplicate culture with <10% variation) performed with NK cell from three independent
donors and two batches of mDC SNs. B, A total of 1 × 106/ml MACS-purified human NK
cells were cultured with 10% p(IC)- or p(AU)-activated mDC SNs in the absence or
presence of neutralizing mouse anti–IL-12p70, anti–IFN-αβR2, anti–IL-15, or mouse IgG as
control (cont. mAb). Data obtained in the presence of the Abs are expressed as percentage of
the activation observed in the absence of Abs and represent mean ± SD from three
independent NK cells donors activated with two different SN batches. C and D, IFN-β and
IL-12p70 concentrations were measured by specific ELISA in SNs of MACS-purified
human mDCs (5 × 105/ml) stimulated 20 h with 50 μg/ml p(IC) or p(AU) (C) or of whole
PBMCs (1 × 106/ml) stimulated 20 h with a dose range of both dsRNA (D). Symbols
represent individual results from four different donors and the horizontal bars the median
(C), and curves represent one representative experiment from one of four donors (D). *p
<0.05; ***p <0.001. E and F, RIG-I, MDA5, TLR3, and IFN-β mRNA levels were
determined by real-time PCR on FACS-sorted NK cells activated with IFN-β (1000 UI/ml),
IL-12 (10 ng/ml), p(IC), p(AU) (both 50 μg/ml) (E) or only p(IC) or p(AU) (F). Results are
expressed as arbitrary units normalized to value for the housekeeping gene GAPDH. Data
represent independent values of three to eight different donors and horizontal bars represent
the median. *p < 0.05; **p < 0.01. p(AU), poly(A:U); p(IC), poly(I:C).
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FIGURE 5.
P(IC) but not p(AU) directly activates NK cells primed with IL-12, type I IFN, or soluble
mediators from dsRNA-stimulated MdDCs. A, A total of 1 × 106/ml MACS-purified human
NK cells were stimulated with the indicated concentrations of IFN-β (A, upper panels) or
IL-12 (A, lower panels) with or without 30 μg/ml p(IC) or p(AU). Degranulation (left) and
IFN-γ (right) production are evaluated as described (Fig. 1). Data are from one of three
representative experiments with three different donors (mean ± SD of culture triplicates). B,
A total of 2 × 106/ml MdDCs were pulsed for 4 h with p(IC) or p(AU), washed, and cultured
for an additional 20 h (pulse-SN) or continuously treated for 24 h with either dsRNA
(continuous-SN). A total of 1 × 106/ml MACS-sorted human NK cells were stimulated with
or without 10% pulsed- or continued-SN from MdDCs alone or in presence of either
dsRNA. IFN-γ production was studied as described (Fig. 1). Data are from one
representative experiment from one of four donors (mean ± SD of culture triplicates).
p(AU), poly(A:U); p(IC), poly(I:C).
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FIGURE 6.
Engagement of TLR3 and RLR on cDCs and RLRs on NK cells is essential for IFN-γ
production. A, A total of 5 × 105/ml MACS-sorted mouse NK cells from TLR3−/−,
Cardif−/−, and WT mice were stimulated with 100 ng/ml IL-12 or 100 μg/ml p(IC) alone or
in combination; 10 ng/ml IL-2 + 100 ng/ml IL-12 were used as positive control. B, A total
of 5 × 105/ml MACS-sorted mouse NK cells from TLR3−/−, Cardif/−, and WT mice were
cultured in the presence of 105/ml MACS-sorted mouse CD11C+ cDCs from WT mice with
or without 100 μg/ml p(IC). C, A total of 5 × 105/ml MACS-sorted mouse NK cells from
WT mice were cultured with 105/ml MACS-sorted cDCs from either WT, TLR3−/−, or
Cardif−/− in the presence of 100 μg/ml p(IC) or 100 ng/ml LPS. A–C, Data are from one of
three representative experiments (mean ± SD of triplicate cultures). Each experiment was
performed with the pool of spleens from at least five animals. D, A total of 1 × 106/ml
MACS-sorted human NK cells were activated with the indicated concentrations of rIL-12
alone or in combination with p(IC), p(AU), or 3pRNA complexed with Lipofectamine 2000.
E, A total of 1 × 106/ml MACS-purified human NK cells were stimulated for 6 h with
Lipofectamine 2000-associated 3pRNA. Cells were then washed twice with ice-cold PBS
and incubated for an additional 20 h with 2 × 105/ml autologous MACS-purified human
mDCs with or without p(A:U) or p(I:C). D and E, Data are from one of three representative
experiments performed with three independent donors (mean ± SD of culture triplicates).
p(AU), poly(A:U); p(IC), poly(I:C).
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FIGURE 7.
Mechanisms that induced optimal production of IFN-γ by NK cells: requirement of
concomitant engagement of TLR3 and RLRs on mDCs and RLRs on NK cells by dsRNA.
Poly(I:C) that triggered both TLR3 and RLR pathway led to high level of IL-12 and type I
IFN production by mDCs, whereas poly(A:U) that activated only TLR3 induced a high
amount of type I IFN but low IL-12. In parallel, poly(I:C)—but not poly(A:U)—was able to
directly activate NK cells via RLRs and allowed them to produce high level of IFN-γ in
combination with IL-12. Cytotoxic potential of NK cells mostly dependent of the type I IFN
produced by dsRNA-activated mDCs and not of a direct triggering by dsRNA was
comparable with both poly(I:C) and poly(A:U).
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